SPEAKERS
We have a great variety of speakers sharing their knowledge with us in February. Stay tuned to find out who else will be speaking at next year's event!
Dr Simone Albrecht, Senior Postdoctoral Research Scientist, N.I.B.R.T
Dr Mark Angelino, Senior Vice President, Pharmaceutical Sciences, bluebird bio
Prof. Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc
Dr Jean-René Authelin, Global Head of Pharmaceutical Engineering, Sanofi
Dr Ahmed Besheer, Group head NBE formulation development - Biologics Drug Product Development, Novartis
Dr Berthold Boedeker, Chief Scientist, Bayer Ag
Dr Cristiana Boi, Researcher, University of Bologna
Dr Harald Bradl, Director Cell Culture Development, Boehringer Ingelheim Pharma GmbH & Co. KG
Dr Christoph Brandenbusch, Group Leader, Bioprocess Separation, TU Dortmund University
Dr David Brindley, Senior Research Fellow in Healthcare Translation, Oxford University
Dr Jorg Brockmann, Head of CMC Process Management, Formycon Ag
Dr Alessandro Butte, Lecturer, ETH Zurich
Dr Manuel Carrondo, Vice President, IBET
Dr Veronique Chotteau, Principal Investigator, K.T.H. Royal Institute of Technology
Professor Klaus Cichutek, President, Paul Ehrlich Institute
Dr Abina Crean, Principal Investigator, University College Cork
Sean Cullen, Developmental SCientist, Sanofi Ireland
Dr Kumar Dhanasekharan, Senior Director and Head of Biologics Process and Analytical Development, Amicus Therapeutics Inc
Dr Simone Dimartino, Lecturer, Institute for Bioengineering, University of Edinburgh
Dr Simon Fischer, Post Doctoral, Boehringer Ingelheim Pharma Gmbh
Dr Tom Fletcher, Scientific Director, Irvine Scientific
Dr Jamie Freeman, Product Manager (Bioproduction), Horizon Discovery
Dr Michael Gillmeister, Senior Scientist Media R&D, Lonza Walkersville, Inc.
Dr Stéphanie Greco, Head of Laboratory, Pharmaceutical Engineering, Sanofi
Dr Hansjörg Hauser, Head of Dept. of Scientific Strategy, Helmholtz Centre for Infection Research GmbH
Dr Charles Haynes, Chemical & Biological Engineering, University of British Columbia
Professor Christoph Herwig, Professor of Biochemical Engineering, Vienna University of Technology
Eric Hickman, Program Manager, Manufacturing Sciences, Biogen Idec
Dr Ewelina Hoffman, Post-Doctoral Fellow, University of Hertfordshire
Dr Jan Jezek, Chief Scientific Officer, Arecor
Dr Dylan Jones, Principal Scientist, Sanofi
Dr Cornelia Kasper, University Professor of Biopharmaceutical Technology, B.O.K.U. University of Natural Resources and Life Sciences Vienna
Dr Hitto Kaufmann, Global Vice President of Biopharmaceutics Development, Sanofi Aventis Deutschland Germany Gmbh
Dr Paul Kelly, Postdoctoral Researcher, National Institute For Cellular Biotechnology
Dr Helene Faustrup Kildegaard, Senior Researcher and Co PI, Technical University of Denmark
Dr Rolf Koehler, Group Head, Novartis Ag
Martin Kornecki, Researcher, Technische Universität Clausthal
Dr Christoph Korpus, Head of Liquid Formulation Stability, Merck
Dr Holger Laux, Fellow, Novartis Pharma
Prof. Julian Ma, Hotung Chair of Molecular Immunology, St George's Univ London Ltd
Dr Jennifer McManus, Senior Lecturer in Chemistry, Maynooth University
Clare Medlow, Technical Sales Manager, Novo Nordisk Pharmatech
Dr Paula Meleady, Associate Director, National Institute for Cellular Biotechnology
Dr Otto Wilhelm Merten, Head of Applied Vectorology and Innovation group, Genethon
Professor Massimo Morbidelli, Professor of Chemical and Bioengineering, ETH Zurich
Dr Anna Münch, Senior Application Specialist, NanoTemper Technologies Gmbh
Dr Darragh O Donovan, Researcher, School of Biomolecular and Biomedical Science, University College Dublin
Dr David O'Connell, Lecturer & Director, Biomolecular & Biomedical Science, University College Dublin
Dr Kerstin Otte, Head of Institute, University of Applied Sciences Biberach
Dr Manfred Papaspyrou, Head Marketing & Sales, Glycotope Biotechnology GmbH
Professor Sergey Piletsky, Professor, University of Leicester
Dr Payal Roychoudhury, Field Applications Scientist, MaxCyte
Dr Oliver Spadiut, Group Leader of Integrated Bioprocess Development, Vienna University of Technology
Dr Gerald Striedner, Assistant Professor, University of Natural Resources and Life Science Vienna B.O.K.U. and Austrian Centre of Industrial B
Dr Joey Studts, Global Bioprocess and Pharma Development, Boehringer Ingelheim Pharma GmbH & Co. KG
Ronen Tchelet, Cive President of Research and Business Development, Dyadic International Inc
Dr Shahid Uddin, Head Of Formulation, MedImmune Cambridge
Dr Nicolas Urbieta, USP Scientist, Sanofi
Dr Ajoy Velayudhan, Professor of Bioprocess Engineering and Biotechnology & EPSRC Manufacturing Fellow, University College London
Mr Alain Vertes, Managing Director, NxR Biotechnologies
Dr Carsten Voss, Application Specialist of Process Chromatography, Bio Rad
Dr Thomas Wucherpfennig, Scientist, Cell Culture Development, Boehringer Ingelheim
Dr Marijke Wynants, MSAT Lead, Sanofi
Dr Christoph Zehe, Head of Technology Development, Cellca Gmbh
Mr Steffen Zobel-Roos, Scientist, Institute of Separation and Process Technology, Technische Universität Clausthal
Organiser
